Multitarget compounds bearing tacrine- and donepezil-like structural and functional motifs for the potential treatment of Alzheimer's disease

Progress in Neurobiology
Lhassane IsmailiJ Marco-Contelles

Abstract

Alzheimer's disease is a multifactorial and fatal neurodegenerative disorder characterized by decline of cholinergic function, deregulation of other neurotransmitter systems, β-amyloid fibril deposition, and β-amyloid oligomers formation. Based on the involvement of a relevant number of biological systems in Alzheimer's disease progression, multitarget compounds may enable therapeutic efficacy. Accordingly, compounds possessing, besides anticholinergic activity and β-amyloid aggregation inhibition properties, metal chelating and/or nitric oxide releasing properties with additional antioxidant capacity were developed. Other targets relevant to Alzheimer's disease have also been considered in the last years for producing multitarget compounds such as β-secretase, monoamino oxidases, serotonin receptors and sigma 1 receptors. The purpose of this review will be to highlight recent reports on the development of multitarget compounds for Alzheimer's disease published within the last years focusing on multifunctional ligands characterized by tacrine-like and donepezil-like structures.

References

Oct 27, 1995·Journal of Medicinal Chemistry·J F KerwinP L Feldman
Apr 6, 1994·JAMA : the Journal of the American Medical Association·P B WatkinsK W Lewis
Apr 15, 1994·Journal of Medicinal Chemistry·R A GlennonK B Howie
Oct 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·M HarelJ L Sussman
Sep 1, 1996·Bioorganic & Medicinal Chemistry·Y KawakamiA J Hopfinger
Mar 3, 1999·Journal of Medicinal Chemistry·J M ContrerasC G Wermuth
Aug 5, 1999·British Journal of Pharmacology·V PérezM Unzeta
Apr 20, 2002·Biophysical Journal·Richard H HenchmanJ Andrew McCammon
Jun 19, 2002·Accounts of Chemical Research·Martin Karplus
Jun 19, 2002·Accounts of Chemical Research·Tongye ShenJ Andrew McCammon
Jun 27, 2002·Japanese Journal of Pharmacology·Hachiro SugimotoYoshiharu Yamanishi
Aug 17, 2002·Bioorganic & Medicinal Chemistry Letters·John K ClarkMing-Qiang Zhang
Aug 23, 2002·Protein Science : a Publication of the Protein Society·Richard H Henchman, J Andrew McCammon
Aug 29, 2002·Journal of the American Chemical Society·Yingkai ZhangJ Andrew McCammon
Aug 29, 2002·Nature Structural Biology·Martin Karplus, J Andrew McCammon
Dec 31, 2002·Brain Research. Brain Research Reviews·Math P Cuajungco, Kyle Y Fagét
Jan 16, 2003·Biochemical Pharmacology·Manuela BartoliniVincenza Andrisano
Apr 2, 2003·European Journal of Medicinal Chemistry·Li DiGuy T Carter
May 22, 2003·The Journal of Biological Chemistry·Jianxin ShiDavid A Johnson
Sep 26, 2003·Biophysical Journal·Jennifer M BuiJ Andrew McCammon
Dec 30, 2003·Journal of Medicinal Chemistry·Roy K HomVarghese John
Jan 8, 2004·Journal of Agricultural and Food Chemistry·Alberto DávalosBegoña Bartolomé
Mar 25, 2004·Lancet Neurology·Xiongwei ZhuMark A Smith
Jun 10, 2004·Journal of the American Chemical Society·Jennifer M BuiJ Andrew McCammon
Nov 24, 2004·The American Journal of Geriatric Pharmacotherapy·John B Standridge
Dec 22, 2004·The Journal of Biological Chemistry·Sayuri TaniguchiMasato Hasegawa
Jul 5, 2005·Bioorganic & Medicinal Chemistry Letters·Rong ShengYongzhou Hu

❮ Previous
Next ❯

Citations

May 18, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Youssef DgachiLhassane Ismaili
Dec 7, 2016·European Journal of Medicinal Chemistry·Alessandra ManciniMaurizio Anzini
Jul 18, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Rona R Ramsay, Keith F Tipton
Apr 4, 2018·Archiv der Pharmazie·Claudio Méndez-RojasHernán Pessoa-Mahana
Sep 6, 2018·Metallomics : Integrated Biometal Science·Karam ChandM Amélia Santos
Jan 18, 2018·Clinical and Translational Medicine·Rona R RamsayMaria Laura Bolognesi
Feb 5, 2019·Journal of Enzyme Inhibition and Medicinal Chemistry·Irene Pachón-AngonaLhassane Ismaili
Feb 15, 2019·Future Medicinal Chemistry·Mohamed Benchekroun, Samuele Maramai
Feb 2, 2019·Current Topics in Medicinal Chemistry·Mridula Saxena, Ragini Dubey
Sep 20, 2017·Future Medicinal Chemistry·Dawid PanekBarbara Malawska
Mar 19, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Irene Pachòn AngonaLhassane Ismaili
Jul 17, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Lazhar ZribiFakher Chabchoub
Mar 23, 2018·Journal of Alzheimer's Disease : JAD·Cheng-Xin GongKhalid Iqbal
Jul 28, 2020·BioMed Research International·Samuele MaramaiSamir Yahiaoui
Nov 30, 2018·Journal of Enzyme Inhibition and Medicinal Chemistry·Youssef DgachiLhassane Ismaili
Feb 10, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Rajeshwari RajeshwariM Amélia Santos
Jul 25, 2020·Journal of Biomolecular Structure & Dynamics·Ana Mércia Silva MascarenhasFranco Henrique Andrade Leite
Nov 29, 2016·Frontiers in Neuroscience·Dubravka Svob StracGiuseppe Di Giovanni
Jul 29, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Agnieszka Zagórska, Anna Jaromin
Jul 28, 2020·ChemMedChem·Rosaria PeroneMaria Laura Bolognesi
Apr 30, 2017·BMB Reports·Md Ataur Rahman, Hyewhon Rhim
Apr 4, 2018·Current Medicinal Chemistry·Maria Jesus Oset-Gasque, Jose Marco-Contelles
Feb 8, 2018·Biochemical Pharmacology·Carey N Pope, Stephen Brimijoin
Oct 10, 2020·Neuropharmacology·Gabriella MarucciFrancesco Amenta
Apr 4, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Fausto QuedaM Amélia Santos

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

© 2022 Meta ULC. All rights reserved